US Bancorp DE cut its stake in Azenta, Inc. (NASDAQ:AZTA – Get Rating) by 19.6% in the 3rd quarter, Holdings Channel reports. The firm owned 62,483 shares of the company’s stock after selling 15,280 shares during the period. US Bancorp DE’s holdings in Azenta were worth $2,678,000 at the end of the most recent quarter.
Several other institutional investors have also added to or reduced their stakes in the stock. CWM LLC grew its position in shares of Azenta by 43.3% in the 3rd quarter. CWM LLC now owns 1,012 shares of the company’s stock worth $43,000 after buying an additional 306 shares during the period. Glassman Wealth Services purchased a new stake in shares of Azenta in the 2nd quarter worth about $25,000. Granite Investment Partners LLC grew its position in shares of Azenta by 0.6% in the 3rd quarter. Granite Investment Partners LLC now owns 55,627 shares of the company’s stock worth $2,384,000 after buying an additional 359 shares during the period. Quadrant Capital Group LLC purchased a new stake in shares of Azenta in the 2nd quarter worth about $26,000. Finally, Castle Wealth Management LLC purchased a new stake in shares of Azenta in the 2nd quarter worth about $34,000. 96.42% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of analysts have recently weighed in on the stock. KeyCorp reduced their target price on shares of Azenta from $90.00 to $70.00 and set an “overweight” rating on the stock in a research report on Monday, October 24th. TheStreet raised shares of Azenta from a “d+” rating to a “c-” rating in a research report on Tuesday, December 13th. Stephens upped their target price on shares of Azenta from $60.00 to $65.00 in a research note on Thursday, November 17th. Finally, Needham & Company LLC upped their target price on shares of Azenta from $74.00 to $78.00 and gave the company a “buy” rating in a research note on Tuesday, November 15th. Four investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of $72.60.
Azenta Stock Down 0.8 %
Azenta (NASDAQ:AZTA – Get Rating) last issued its quarterly earnings data on Monday, November 14th. The company reported $0.16 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.10. Azenta had a net margin of 383.23% and a return on equity of 1.31%. The firm had revenue of $137.57 million for the quarter, compared to analysts’ expectations of $132.01 million. Analysts expect that Azenta, Inc. will post 0.33 earnings per share for the current fiscal year.
Azenta, Inc provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows.
- Get a free copy of the StockNews.com research report on Azenta (AZTA)
- MarketBeat: Week in Review 01/09-01/13
- JPMorgan Chase Falls As Banks Brace For Recession
- Why is the Bed Bath & Beyond Stock Price up 261%?
- Roku Stock Price is Trending, Here’s Why
- Carvana Stock Rally, Here’s What You Need to Know
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.